昊帆生物
(301393)
| 流通市值：21.34亿 | | | 总市值：54.75亿 |
| 流通股本：4210.48万 | | | 总股本：1.08亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 434,698,213.66 | 270,298,471.51 | 135,213,242.04 | 451,874,668.1 |
| 营业收入 | 434,698,213.66 | 270,298,471.51 | 135,213,242.04 | 451,874,668.1 |
| 二、营业总成本 | 336,820,135.14 | 200,149,046.57 | 102,006,985.59 | 320,336,611.16 |
| 营业成本 | 266,268,640.36 | 161,306,618.37 | 82,708,972.55 | 269,852,206.07 |
| 税金及附加 | 4,667,491.6 | 2,656,055.4 | 1,416,117.8 | 4,178,065.22 |
| 销售费用 | 12,726,014.71 | 8,051,955.73 | 3,832,441.99 | 13,596,937.8 |
| 管理费用 | 30,740,506.56 | 14,923,747.55 | 7,148,311.3 | 29,529,803.99 |
| 研发费用 | 30,612,903.47 | 19,260,122.3 | 9,861,294.55 | 35,991,848.34 |
| 财务费用 | -8,195,421.56 | -6,049,452.78 | -2,960,152.6 | -32,812,250.26 |
| 其中:利息费用 | 504,290.66 | 49,404.41 | 26,566.61 | 91,293.5 |
| 其中:利息收入 | 12,832,185.57 | 7,544,180.7 | 3,408,207.74 | 29,727,232.8 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 7,813,884.37 | 5,444,086.14 | 1,317,903.57 | 5,636,108.35 |
| 加:投资收益 | 12,609,547.77 | 9,950,840.4 | 6,025,752.73 | 10,950,889.64 |
| 资产处置收益 | -93,989.15 | -93,989.15 | -93,989.15 | -32,052.89 |
| 资产减值损失(新) | -13,243,008.25 | -610,495.36 | -386,538.6 | -2,661,553.64 |
| 信用减值损失(新) | 3,740,734.34 | -387,503.22 | -1,141,392.53 | -2,509,435.62 |
| 其他收益 | 5,894,088.12 | 2,653,970.82 | 1,438,915.64 | 12,969,342.67 |
| 四、营业利润 | 114,599,335.72 | 87,106,334.57 | 40,366,908.11 | 155,891,355.45 |
| 加:营业外收入 | 116,822.93 | 44,752.12 | 4,876.22 | 120,434.03 |
| 减:营业外支出 | 889,406.87 | 31,795.45 | 933.23 | 1,375,650.43 |
| 五、利润总额 | 113,826,751.78 | 87,119,291.24 | 40,370,851.1 | 154,636,139.05 |
| 减:所得税费用 | 14,588,403.86 | 11,234,489.25 | 5,571,873.66 | 20,583,221.99 |
| 六、净利润 | 99,238,347.92 | 75,884,801.99 | 34,798,977.44 | 134,052,917.06 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 99,238,347.92 | 75,884,801.99 | 34,798,977.44 | 134,052,917.06 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 99,238,347.92 | 75,884,801.99 | 34,798,977.44 | 134,052,917.06 |
| 扣除非经常损益后的净利润 | 81,271,955.04 | 62,000,384.85 | 28,015,509.2 | 115,649,120.14 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.93 | 0.71 | 0.33 | 1.25 |
| (二)稀释每股收益 | 0.92 | 0.7 | 0.32 | 1.24 |
| 八、其他综合收益 | 132,740.77 | 142,913.01 | 25,030.11 | - |
| 归属于母公司股东的其他综合收益 | 132,740.77 | 142,913.01 | 25,030.11 | - |
| 九、综合收益总额 | 99,371,088.69 | 76,027,715 | 34,824,007.55 | 134,052,917.06 |
| 归属于母公司股东的综合收益总额 | 99,371,088.69 | 76,027,715 | 34,824,007.55 | 134,052,917.06 |
| 公告日期 | 2025-10-29 | 2025-08-29 | 2025-04-28 | 2025-04-11 |
| 审计意见(境内) | | | | 标准无保留意见 |